Crescendo Bioscience Secures $31,000,000 Series C Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8332f09c-f928-48a1-a652-ca65e0da9b7c&Preview=1
Date
9/8/2011
Company Name
Crescendo Bioscience
Mailing Address
341 Oyster Point Blvd South San Francisco, CA 94080
Company Description
Crescendo Bioscience is developing a broad range of quantitative, objective diagnostic tools to provide Rheumatologists with deeper clinical insights to more effectively manage patients with autoimmune and inflammatory diseases.
Website
http://www.crescendobio.com
Transaction Type
Venture Equity
Transaction Amount
$31,000,000
Transaction Round
Series C
Proceeds Purposes
The company will use the funding to accelerate commercialization of its Vectra DA diagnostic test and expand its pipeline of molecular diagnostic products for rheumatoid arthritis and other inflammatory diseases.
M&A Terms
Venture Investor
Aeris Capital AG
Venture Investor
Kleiner Perkins Caufield & Byers
Venture Investor
Mohr Davidow Ventures